Our findings, overall, align with a study that demonstrated tumor cell-intrinsic EphA2 inhibits anti-tumor immunity in pancreatic cancer through the regulation of PTGS2, the gene encoding cyclooxygenase-2 (COX2) [22]. This evidence concerns the gene EPHA2 and pancreatic neoplasm.